SAVIENT PHARMACEUTICALS INC: cashflow_investing
| Value | {"amount": -28030000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2011-01-01 – 2011-09-30 |
| Status | current |
| Entity | SAVIENT PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:42:10.707571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/be3ca129-bf17-42b7-b02f-04258fafa353
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-460442 · Open the official SEC filing →Retrieved: 2026-08-19T07:42:10.707571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000722104/cashflow-investing/2011-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/be3ca129-bf17-42b7-b02f-04258fafa353
History
- supersedes {"amount": -28026000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} (evidence 0001193125-11-302386)